Standard BioTools Inc (LAB)
2.40
-0.01
(-0.41%)
USD |
NASDAQ |
May 10, 16:00
2.405
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Total Liabilities (Quarterly): 471.12M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 471.12M |
| September 30, 2023 | 471.00M |
| June 30, 2023 | 469.21M |
| March 31, 2023 | 468.81M |
| December 31, 2022 | 471.78M |
| September 30, 2022 | 477.66M |
| June 30, 2022 | 478.58M |
| March 31, 2022 | 249.82M |
| December 31, 2021 | 180.62M |
| September 30, 2021 | 182.85M |
| June 30, 2021 | 179.86M |
| March 31, 2021 | 182.26M |
| December 31, 2020 | 185.71M |
| September 30, 2020 | 171.00M |
| June 30, 2020 | 149.63M |
| March 31, 2020 | 148.72M |
| December 31, 2019 | 111.20M |
| September 30, 2019 | 106.79M |
| June 30, 2019 | 111.15M |
| March 31, 2019 | 109.20M |
| December 31, 2018 | 231.53M |
| September 30, 2018 | 229.88M |
| June 30, 2018 | 224.27M |
| March 31, 2018 | 221.13M |
| December 31, 2017 | 256.42M |
| Date | Value |
|---|---|
| September 30, 2017 | 252.93M |
| June 30, 2017 | 254.77M |
| March 31, 2017 | 253.96M |
| December 31, 2016 | 253.16M |
| September 30, 2016 | 252.45M |
| June 30, 2016 | 257.77M |
| March 31, 2016 | 255.46M |
| December 31, 2015 | 255.15M |
| September 30, 2015 | 254.36M |
| June 30, 2015 | 255.91M |
| March 31, 2015 | 252.58M |
| December 31, 2014 | 257.14M |
| September 30, 2014 | 255.84M |
| June 30, 2014 | 255.92M |
| March 31, 2014 | 257.29M |
| December 31, 2013 | 20.50M |
| September 30, 2013 | 17.23M |
| June 30, 2013 | 13.58M |
| March 31, 2013 | 13.11M |
| December 31, 2012 | 13.08M |
| September 30, 2012 | 14.44M |
| June 30, 2012 | 16.01M |
| March 31, 2012 | 18.77M |
| December 31, 2011 | 22.43M |
| September 30, 2011 | 23.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
106.79M
Minimum
Sep 2019
478.58M
Maximum
Jun 2022
277.25M
Average
182.85M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Bruker Corp | 3.056B |
| Azenta Inc | 340.63M |
| Harvard Bioscience Inc | 64.35M |
| Bionano Genomics Inc | 75.22M |
| Akoya Biosciences Inc | 126.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 323.07M |
| Shareholders Equity (Quarterly) | -148.05M |
| Debt to Equity Ratio | -0.429 |
| Current Ratio | 1.447 |
| Net Debt Paydown Yield | 0.14% |